Latest Sustainability News

Hawk Resources reports high-grade copper mineralisation at Utah's Cactus project and secures an option to acquire up to 80% of Arizona's Meerkat copper project, while progressing scandium exploration in Western Australia.

Mesoblast Limited posted US$30.3 million in net revenues for Ryoncil® in Q3 2026, hitting key clinical milestones and securing new technology licenses that could boost its next-generation cell therapies.

Freehill Mining’s aggregates business surged with a 59% jump in quarterly sales, while new copper project options promise to shift the company’s growth trajectory.

Omni Bridgeway reports strong investment activity and a robust pipeline for Q3 2026, maintaining solid returns and cost discipline amid global market volatility.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.

Black Rock Mining is closing in on full construction readiness at its Mahenge Graphite Project after completing key early works and advancing funding discussions amid improving graphite prices.

Botala Energy’s Serowe CBM Project advances as key production well 3.5B reaches 83% depth with multiple support wells actively managing reservoir pressure and gas flows confirmed from pilot operations.

IMEXHS Limited kicked off FY26 with a 13% revenue increase and a strategic pivot to an AI-native radiology workflow platform, securing major contracts in Latin America and advancing proprietary AI agents.

Alpha HPA Limited reports robust progress on its HPA First Project Stage 2, backed by a $225 million capital raise, while securing significant demand upgrades from Japanese semiconductor customers.

Aureka Limited extends its Victorian gold resource ambitions with strong drilling results at Irvine and Comstock, backed by fresh geophysical data and secured tenure.

Zimi Limited posted 14% revenue growth and landed its biggest project order to date with Homecorp, while slashing operating costs and launching an AI sales agent.

Little Green Pharma (ASX:LGP) posted record quarterly and annual revenues driven by a surge in European sales, improved cashflow, and reduced debt. The company is on track to complete its merger with Cannatrek by June 1, 2026, while benefiting from the US rescheduling of medicinal cannabis to Schedule III.